I will attend AGM… first one in Malaysia! Hopefully this time it is not online!

Eagleye….what you are saying is a strong probability….they use nominee accounts to deal on their behalf….and is a tactic used often… I have been stating this. Already the shares have underperformed by 40%- 80% compared to other companies…and as you say there is no communication or defence what so ever. I can say they are easily one of the worst management of public companies and they have a very poor governance
Culture. That said I am very optimistic about TauRX… very likely MHRA will approve not too sure about the FDA. So a rally is a strong probability

I am pretty sure contracts are awarded to people of interest by Genting …so all expenditure is to connect people for sure ….predictive behaviour

Poor governance culture as been pointed out many times over. Fuddy duddy management, monolithic in style rely on corruption and favours to make money. No culture to promote shareholder interests other than owners at the expense of other shareholders and miniority shareholders including associates. Management should go, but he won’t ……until something permanent happens

I had eluded few weeks back that the fact NICE is meeting in Feb to discuss coast effectiveness of the drug for NHS use suggests to me they are confident that it will be approved. As there many people involved in the meeting, which would be waste of time if it was not likely to get approval. This is for UK of course.

LKT, said his intention is to keep TauRX medication cheap. I think he actually meant he intends to keep Genting share price cheap! Miscommunication as his communication skills are extremely doggy.

Where is LKT? Does this guy communicate? Never heard ho speak… I guess not missing anything. Lousy leader not to rely on when matter of life and death… he will not be on the front line but hiding some where in the barracks! That’s my summation of him.

Keep blaming the government! Very delusional! How about other counters who are doing well? Blame the govt there as well I suppose! If I were Genting I would be careful about listing on US , I can few individuals being jailed and taken to cleaners. Better stick to Asia for
Malpractice and poor ethics.

I told you guys this guy the super hero for some, big boss to others makes his money from the Genting company structure and other shareholders! He uses the ltd structure to reap havoc, simple that’s why he won’t exit as boss as he controls all decisions and the independent risk committee is not independent and same for remuneration committee. You need a coup! Perhaps inject Covid infection or something drastic… as he aint moving

@mushimushi…..absolutely correct re colonisers. The gang is US, Australia, Canada, New Zealand and master U.K. you can also add Germany and France……we should not be surprised if their behaviour. . They are at the heart of the worlds problems….read history and find out now many countries were raped and pillaged by U.K. nothing changes …they are still at it …now they appoint migrant servants and slaves to do their dirty job, Sunak, Patel, Suealla and Kemi latest head of Conservative party. As long as USD is used for business countries will remain exposed…to their politics

On positive note, I am feeling confident at TaURX….NHS needs a cost effective treatment! So gets ready!

Genting expansion into US, New York, is very risky given Genting’s governance issues and unethical behaviour by owners. Likely to face law suits as they can’t expect to get away with their behaviour as they do in Asian markets! Old man better rethink strategy.

So called analysts have a buy call on Genting and this has been the case for some time. Yet they never discuss why share price is in down trend for some time. We know why this is the case…. Governance issue with mgt. this is never discussed why? Analysts are double agents. They should be held accountable and controlled by Bursa.

Let’s be honest lot of these old family owned companies like YTL Genting benefited from old style,of doing business which relied on favours and corruption to get contracts …the world is moving on. Look at China, they have brought to justice many corrupt corporates…..corruption involves 2 parties one which pays to get business without competing, and the other t party awarding contracts without getting necessarily a big reward…anthying was sufficient. In South Africa, black African natives were not able to get mortgages or loans to buy anything and the whites dominated buying properties which rose….90% of CT in hander of these people…not that they were brilliant but were in power hence to this day they have financial,control. Not much different here.

Only saviour is coming be alert…..for dumping shares before it reacts to news.

Governance failure …market does not trust management ie CEO. He can any time do party related transaction dump expenses on to associates, dump shares, etc…it is behaviour deficit….otjerwise more than 50% under valued!

I have been hacked I can’t type ..hence lot of typos …not wowed strong a sentence!

Genting is worst performing share counter in its peer group. Most have achieved 40-90% returns ….whilst this ugly duck has struggled despite revenue recovering and valuation metrics suggesting 50% undervalued. So why? Well we know it’s down to CEO, first as an inept leader completely lacking in foresight and unwilling to hand over reigns to professional independent manager. Secondly he is ethical and his focus is to make money from the company structure by dumping shares from time to time and to exercise party related transaction….passing over is owned assets to company at unreasonable value and also to pass on expenses etc….which I beleive is partly why the US associate is complaint about. All consistent with poor shareholder governance. Any way on the positive side at the current price shares are being snapped up….watch out of TauRX news we may see some bad needs further drop the price before the good news! With this counter all is a possibility.

Ceo

Genting management morally, ethically, physiologically, corrupt and devoid of ideas. The only way big boss knows how to make money is from other shareholders. He is too old and out of sink with current business trends… does he care? No because his objective of making money is through company structure as he holds 40% of stock!

I for one have always stated that there are significant Governance issues with Genting and it’s old management. They are old style operators…..bit beyond sell by date. Also they are morally and ethically not to be relied on. They originate from an era where corruption and favours are central part of doing business and do t really care about the shareholders. Despite this the shares using recognised valuation tools are undervalued to the tune of 40-50%. For fortunes to change, we need new investors, a catalyst changer and definite change in CEO….is this likley to happen? We may have a catalyst of sorts and perhaps have to wait little longer for cultural and management change which is very badly needed. Meanwhile let’s hope for a change in fortune. Most companies would have had change in CEO when first trend of underperformance became apparent …..we are talking 12 years ago.

By the way I am not against constructive arguments being put forward….it is the constant bickering and endless use of historic posts ….this no use to any one and quite boorish really. Comments can be positive or negative but nit based on bias! We are here to make money! Hope that is true for all!

My view on Taurx….NICE have set up a meeting to discuss cost effectiveness of Taurx …..on 25 Feb 2025. Official report will be released if Taurx is cost effective and suitable drug for cash strapped NHS to deploy. My thinking is they would not start this process unless they are reasonably confident that MHRA will give the approval and this can officially any time between 31 Dec and February 2025. All exciting stuff. What we don’t know is the reaction in share price if MHRA give the approval! Any views, please share? Genting needs this badly…..given its latest governance issues in US. I say governance, becuase it is just that and have history of impropriety, with its shareholder and passing the buck to shareholders, in this case allocating unreasonable costs to an associate company. Sounds perfectly feasible given their pass behaviour, but does it warrant such damages not too sure.

Now we are hearing something constructive and useful in this forum….thank you ATK

What a useless forum

What a forum! Made up of people behaving like poorly brought up children! I have seen nothing like this before. Constantly hurling abuse, seem to have plenty of spare time to spend arguing amongst yourselves. Hire a ring and address the issue instead of boring us to death.

The big issue with Genting remains GOVERNANCE….MGT CANNOT BE TRUSTED …SADLY….ONLY WAY TO ADDRESS THIS IS TO HAVE NEW PROFESSIONAL CEO and compliance team.

Taurx approval likely be Dec this year.

Just returned from U.K., where there is strong consensus of Taurx getting the approval. NHS can’t afford, the drug that was approved few days back….which is expensive as has side effects.

We will hear from MHRA in October, 2024! So tighten your belt.

I concur with sentiments made by members in this forum on MHRA will be the first to approve TauRX. Don’t forget TaURX is based in Aberdeen and naturally has some relationship with the authorities in the UK. Also TaURX with its low implementation costs suits cash strapped NHS. Under the new fast track approval process the timeline suggests we could see action during 4th qtr! Fingers crossed. Genting insiders is my big concern as in the past have proven to be untrustworthy, perhaps they may changed the spots!

Trade war will start again! No trade war has been in place since Trump first came to power….democrats if anything put more pressure…so nothing new …same of the same no matter who is in power…at least Russia Ukraine war will end…under Trump..

Indeed Genting is a big laggard. It needs a catalyst. It seems there are nobody willing to chase. When time comes like an earthquake it will catapult! Wait at the starting blocks. Anytime after Sept I say.

@AngTayKor, I understand. Not a level playing field. Loaded with politics. They protect their own. I suspect MHRA could be 1st.

Placebo issue has a precedent where by a drug was approved without the use of placebo. So technically speaking TauRX could address the issue.

@save they may be selling anything above that 1630 fair dues, but Genting has made no such recovery all other counters have had a good run! Except Genting and still we have faith in the old far. Only saviour is TauRX and MHRA and not US as they won’t approve non US based pharmaceuticals unless they have huge presence in US. US by this means is not open market for sure just pretend.

Large volume of sales…. Guess who that must be? Ask Maybank they have this periodic push log Genting only immediately to be called by sales. Jokers

Here we go again! It is same IB from Maybank periodic pushing Gentings case. It is perennial, some family member is selling! Also don’t keep
Blaming foreign funds, selling, look at their holdings no significant change in holdings from
What I can see. I still think worth waiting until year end. One may see something happening during 4th qtr!

TauRX is only hope for Genting others such listing in US is questionable or perhaps when LKT is gone as his governance style may be problematical for us listing! As to TauRX don’t forget application to UK is under fast track … I still think there is good chance this year!

Down trend since 2011…..need dramatic change…..only one thing can provide all other ideas of no value.

No doubt Genting is trading at considerable discount and for it narrow we need to see more shareholder focussed action so that we can all enjoy the returns

@Koosan, no need to be rude! We are investors wanting the company to do well and generate returns to the shareholders… nothing else! Sometimes you have to accept the truth no matter how bitter. I remain invested because I want Genting to move away from the past and get investors confidence! Confidence current and future shareholders os important if we want share price to rise and provide returns to shareholders who are patiently waiting!

Let’s see some
Postive momentum! Last of the significant counters to have a good rally! 3rd Qtr could do it!

We need to see new year high to be on up trend, then only, can we be confident of sentiment change. As to Taurus, definitely we should hear something during the 3rd or early 4th qtr of this year particularly from U.K. regulatory body.

Need to see 5.20 plus to be on uptrend!

Watch out for usual trick suspension of trades when announcing new projects!

Just a reminder to some who think we are very critical of LKT and Genting! Look at the facts, it has been in drown trend basically from 2011 onwards price peaked than. That is many years of under performance! Reason, is well publicised. We hope the worst is over. Countries do have generally have leaders for more to 10 years. Here we have ceo who has been head for many many years. I like to think new blood and vision is needed and good for company. Also famiky appointnents
Big issue. If you want US listing all this needs to change. Meanwhile we wait for TAuRX

You have to really ask why this counter does not go up compared to others! It is nothing to do with actual business as but more about past behaviours and governance issues. Simple as that!

All possibilities but no substance

If Genting is successful in listing in US, it better sort out governance issues! Risk of fines will be very higher but also for shareholders to take action against improper behaviour